Condition: Cochlear Implants · Hearing Loss, Sensorineural · Sponsor: Radboud University Medical Center
This is a prospective multicenter multinational randomized control trial. The duration of the study for the individual patient will be approximately 1 year (pre-operative assessments, 1 week, 3 months and 12 months follow-up assessments). Participants will be randomized to one of two surgical approaches: eRW or CO, with a 1:1 allocation in a parallel design.
This description comes directly from the study's public registry record.
Coby Lindeboom, MD · 024 361 14934 · Coby.lindeboom@radboudumc.nl
Emmanuel Mylanus · Emmanuel.Mylanus@radboudumc.nl
Always discuss trial participation with your own doctor first.
| Radboud University Medical Center | Nijmegen, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06453343